Ginger and Psoriasis: Skin Inflammation, IL-17 & Plaques

Direct Answer: Ginger for psoriasis is an auto-inflammatory disease mediated by the IL-23/IL-17 axis and keratinocyte hyperproliferation. Ginger acts via 4 convergent pathways: NF-κB inhibition (reduces TNF-α, IL-1β, IL-6), Th17 suppression (reduces IL-17 by 30–40% in vitro), keratinocyte proliferation inhibition via EGFR, and VEGF reduction (plaque angiogenesis). There are no specific RCTs for human psoriasis, but the mechanisms are robust and several positive case studies exist.

Psoriasis in Belgium

Psoriasis affects 2–3% of the population — approximately 250,000 Belgians. It is a chronic, relapsing disease with phases of aggravation (flare-ups) and remission. Its impacts are: physical (itching, pain), psychological (stigma, ginger depression) and joint-related (ginger for psoriatic arthritis in 30% of patients). The costs of biological treatments (IL-17, IL-23 biotherapies) can exceed €15,000/year.

Anti-psoriatic Mechanisms of Ginger

1. Suppression of the IL-23/IL-17 axis

IL-23 (produced by dendritic cells) activates Th17 cells, which secrete IL-17A — a key cytokine that causes keratinocyte hyperproliferation and erythematosquamous plaques. 6-shogaol reduces IL-17 secretion by Th17 cells by 30–40% by inhibiting the RORγt pathway (master transcription factor for Th17 cells). This mechanism is similar to anti-IL-17 biotherapies (ixekizumab, secukinumab), but with incomparably lower efficacy.

2. NF-κB Inhibition in Keratinocytes

NF-κB is hyperactive in psoriatic keratinocytes, driving the production of chemokines (CXCL1, CXCL8) that recruit neutrophils and perpetuate inflammation. Gingerols inhibit NF-κB activation in human HaCaT keratinocytes exposed to TNF-α, reducing CXCL8 (IL-8) by 55%.

3. Reduction of keratinocyte proliferation

Hyperproliferation (7× accelerated skin turnover) is the driver of plaques. 6-gingerol inhibits EGFR (epidermal receptor) signaling in keratinocytes, reducing their proliferation by 25–30% in vitro. This antiproliferative effect complements ginger's anti-inflammatory action.

4. VEGF inhibition → angiogenesis reduction

Psoriatic plaques are hypervascularized (high VEGF). Gingerols reduce VEGF expression in endothelial skin cells, contributing to the reduction of erythema (redness) of the plaques.

INTI: Internal & External Approach

Internal (systemic) pathway

Phase INTI Dosage Synergistics
Flare-up 2 bottles/day Omega-3 3g (EPA+DHA), curcumin 500 mg
Remission/prevention 1 bottle/day Vitamin D₃ 3000 IU (essential for psoriasis)

Triggers to avoid (interaction with ginger intake)

"My plaque psoriasis has been chronic for 15 years. After 5 months of daily INTI + vitamin D₃ + omega-3, my plaques are significantly less widespread and the itching is much more bearable between flare-ups." — Nicolas, 42, Charleroi

Comparison of Psoriasis Approaches

Approach Mechanism Level of Evidence Cost/month
Anti-IL-17/IL-23 Biotherapies Direct Blockade Very High (RCT) ~€1,200
Methotrexate Antiproliferative High ~€20
INTI + omega-3 + vitD NF-κB + IL-17 + VEGF Moderate (mech.) ~€65
Topical Cortisone Local Anti-inflam. High (topical) ~€15

FAQ Ginger & Psoriasis

Can ginger replace biotherapies for psoriasis?

No. Anti-IL-17/IL-23 biotherapies have incomparably greater efficacy (PASI 90 in 50–70% of cases). Ginger is a natural supplement for mild to moderate forms or between treatments, not an alternative to biotherapies in severe psoriasis.

Does ginger also help with psoriatic arthritis?

Yes — doubly indicated: articular anti-inflammatory (inhibits COX-2, reduces TNF-α, IL-1β) AND cutaneous anti-inflammatory. See also the INTI article on rheumatoid arthritis for joint mechanisms.

Topical ginger for psoriasis?

Some topical ginger preparations exist, with moderate pruritic effects. Systemic action via oral route is better documented for psoriasis (systemic cytokines). Both approaches are complementary.

References: Kim et al. J Immunol 2013; Kaur et al. Int J Dermatol 2016; Prasad et al. J Med Food 2014.

Related Articles

To learn more, also read:

Back to blog